ClinicalTrials.gg
CompletedNCT01223261NEC SurgeryUpdated Mar 22, 2019

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

An observational study in Infant, Newborn, Infant, Low Birth Weight and Infant, Small for Gestational Age, sponsored by NICHD Neonatal Research Network. Completed at 17 sites in United States. Open to participants aged Up to 6 Weeks. Per ClinicalTrials.gov, last updated 2019-03-22.

Sponsored by NICHD Neonatal Research Network · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
156
Ages
Up to 6 Weeks
Sex
All
01

Study summary

The purposes of this study were: 1) to compare mortality and postoperative morbidities in extremely low birth weight (ELBW) infants who underwent initial laparotomy or drainage for necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP); 2) to determine the ability to distinguish NEC from IP preoperatively and the importance of this distinction on outcome measures; and 3) to evaluate the association between extent of intestinal disease determined at operation and outcome measures. All ELBW infants born at participating NRN centers were screened for the presence of NEC or IP that was thought by the pediatric surgeon and neonatologist to require surgical intervention. Data were collected enrolled infants, including: intraoperative findings recorded by the surgeon and specific post-operative complications. Neurodevelopmental examinations were conducted on surviving infants at 18-22 months corrected age.

Read the detailed description

Necrotizing enterocolitis (NEC) is a condition, generally affecting premature infants, in which the intestines become ischemic (lack oxygen and/or blood flow). NEC occurs in up to 5-15% of extremely low birth weight (ELBW) infants. Isolated or focal intestinal perforation (IP) is a less common condition, affecting an estimated 4% of ELBWs, in which a hole develops in the intestines leaking fluid into the abdomin. The outcomes for infants with NEC or IP are poor: 49% die and half of the surviving infants are neurodevelopmentally impaired.

Surgical options for NEC and IP include two possible procedures: peritoneal drainage, in which a tube is placed in the abdominal cavity through a small incision for fluid to drain out; or laparotomy, in which an incision is made in the abdomen and diseased intestine is removed. Infants treated with an initial drainage sometimes go on to need a laparotomy. Most surgeons now believe that a diagnosis of the intestinal perforation (IP) may actually be either true NEC or a different and distinct pathology, termed isolated intestinal perforation. The ability to distinguish these 2 conditions preoperatively, based on perinatal characteristics, physical examination findings, and findings on abdominal plain film imaging, remains unknown. If these 2 entities can be distinguished preoperatively, the intervention chosen and outcomes may be different. From the two available surgical options, tt is not known whether initial laparotomy or peritoneal drain placement is more effective for either NEC or IP.

This study was a prospective, multicenter observational study to describe the surgical outcomes (mortality, post-operative intestinal stricture, intra-abdominal abscess formation, etc.) in ELBW infants with either NEC or IP who underwent initial laparotomy or peritoneal drainage. We also evaluated the ability of surgeons to distinguish NEC and IP pre-operatively and the relevance of this distinction on outcome. Finally, an analysis of the impact of extent of intestinal involvement with NEC on outcome measures is reported.

All ELBW infants born at participating NRN centers were screened for the presence of NEC or IP that was thought by the pediatric surgeon and neonatologist to require surgical intervention. Data were collected enrolled infants, including: intraoperative findings recorded by the surgeon and specific post-operative complications.

Neurodevelopmental examinations were conducted on surviving infants at 18-22 months corrected age.

02

Conditions studied

  • Infant, Newborn
  • Infant, Low Birth Weight
  • Infant, Small for Gestational Age
  • Infant, Premature
  • Enterocolitis, Necrotizing
  • Intestinal Perforation

Keywords

  • NICHD Neonatal Research Network
  • Very Low Birth Weight (VLBW)
  • Extremely Low Birth Weight (ELBW)
  • Prematurity
  • Laparotomy
  • Drainage
  • Isolated intestinal perforation
  • Focal intestinal performation
03

In context

Premature Birth

2,550 studies on the registry are indexed under Premature Birth; 500 are open to participants now.

This study's enrollment of 156 is above the median of 120 across 806 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

NICHD Neonatal Research Network is the lead sponsor of 63 studies on the registry; 5 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 7 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 6 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Extremely Low Birth Weight (ELBW) infants (those with birth weights \<1000 g) born at participating NRN Centers diagnosed by a pediatric surgeon and neonatologist as having either necrotizing enterocolitis (NEC) or intestinal perforation (IP) requiring surgical intervention.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants born 401-1,000 grams at birth enrolled in the NRN Generic Database
  • Sage III NEC or isolated intestinal perforation
  • Pediatric surgeon decision to perform surgery for suspected NEC or IP

Exclusion criteria

Exclusion Criteria:

  • Decision not to treat
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
156 participants (actual)
06

What researchers measure

Primary outcomes

  1. Feasibility of conducting a randomized trial

    Ability to enroll infants in a 1-year period

    Time frame: 1 year

Secondary outcomes

  1. Document variation in current surgical practices

    Time frame: Until hospital discharge or 120 days of life

  2. Prevalence of infants who would qualify for the study

    Time frame: Until hospital discharge or 120 days of life

  3. Frequency of postoperative complications

    Time frame: Until hospital discharge or 120 days of life

  4. Neurodevelopmental impairment

    Time frame: 18-22 months corrected age

07

Study locations

17 sites
  • University of Alabama at Birmingham
    Birmingham, Alabama 35233, United States
  • Stanford University
    Palo Alto, California 94304, United States
  • University of California at San Diego
    San Diego, California 92103-8774, United States
  • Yale University
    New Haven, Connecticut 06504, United States
  • University of Miami
    Miami, Florida 33136, United States
  • Emory University
    Atlanta, Georgia 30303, United States
  • Indiana University
    Indianapolis, Indiana 46202, United States
  • Wayne State University
    Detroit, Michigan 48201, United States
  • University of Rochester
    Rochester, New York 14642, United States
  • Wake Forest University
    Charlotte, North Carolina 27157, United States
  • RTI International
    Durham, North Carolina 27705, United States
  • Duke University
    Durham, North Carolina 27710, United States
  • Cincinnati Children's Medical Center
    Cincinnati, Ohio 45267, United States
  • Case Western Reserve University, Rainbow Babies and Children's Hospital
    Cleveland, Ohio 44106, United States
  • Brown University, Women & Infants Hospital of Rhode Island
    Providence, Rhode Island 02905, United States
  • University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas 75235, United States
  • University of Texas Health Science Center at Houston
    Houston, Texas 77030, United States
08

References and documents

Publications

  • Blakely ML, Lally KP, McDonald S, Brown RL, Barnhart DC, Ricketts RR, Thompson WR, Scherer LR, Klein MD, Letton RW, Chwals WJ, Touloukian RJ, Kurkchubasche AG, Skinner MA, Moss RL, Hilfiker ML; NEC Subcommittee of the NICHD Neonatal Research Network. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg. 2005 Jun;241(6):984-9; discussion 989-94. doi: 10.1097/01.sla.0000164181.67862.7f. PubMed 15912048 ↗
  • Blakely ML, Tyson JE, Lally KP, McDonald S, Stoll BJ, Stevenson DK, Poole WK, Jobe AH, Wright LL, Higgins RD; NICHD Neonatal Research Network. Laparotomy versus peritoneal drainage for necrotizing enterocolitis or isolated intestinal perforation in extremely low birth weight infants: outcomes through 18 months adjusted age. Pediatrics. 2006 Apr;117(4):e680-7. doi: 10.1542/peds.2005-1273. Epub 2006 Mar 20. PubMed 16549503 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 22, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01223261
Lead sponsor
NICHD Neonatal Research Network
First posted
Oct 18, 2010
Start date
Mar 2001
Primary completion
Sep 2002
Completion
Mar 2004
Last update
Mar 22, 2019

Study contacts

Martin L. Blakely, MD
study director · The University of Texas Health Science Center, Houston
Waldemar A. Carlo, MD
principal investigator · University of Alabama at Birmingham
William Oh, MD
principal investigator · Brown University, Women & Infants Hospital of Rhode Island
Avroy A. Fanaroff, MD
principal investigator · Case Western Reserve University, Rainbow Babies & Children's Hospital
Edward F. Donovan, MD
principal investigator · Children's Hospital Medical Center, Cincinnati
Barbara J. Stoll, MD
principal investigator · Emory University
Charles R. Bauer, MD
principal investigator · University of Miami
James A. Lemons, MD
principal investigator · Indiana University
David K. Stevenson, MD
principal investigator · Stanford University
Abbot R. Laptook, MD
principal investigator · University of Texas
Seetha Shankaran, MD
principal investigator · Wayne State University
Richard A. Ehrenkranz, MD
principal investigator · Yale University
Ronald N. Goldberg, MD
principal investigator · Duke University
T. Michael O'Shea, MD MPH
principal investigator · Wake Forest University
Dale L. Phelps, MD
principal investigator · University of Rochester
Neil N. Finer, MD
principal investigator · University of California, San Diego
W. Kenneth Poole, PhD
principal investigator · RTI International

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion